Dow Down 0.18% Nasdaq Down 0.33%

Ironwood Pharmaceuticals, Inc. (IRWD)

-NasdaqGS
13.56 Oct 29, 4:00PM EDT
Prev Close:13.56
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:14.42
Beta:1.94
Next Earnings Date: 4-Nov-14IRWD Earnings announcement
Day's Range:N/A - N/A
52wk Range:8.95 - 15.95
Volume:0
Avg Vol (3m):1,211,400
Market Cap:1.89B
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IRWD

Comparison

Symbol% ChgMkt Cap
IRWD 0.00%1.89B
SHPG38.48B
SCMP365.03M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):60.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback